Assessment of the fate of myocardial necrosis by serial myocardial perfusion imaging
- 82 Downloads
Myocardial necrosis after myocardial infarction (MI) is common; extent and severity are however variable. The pattern is recognized by myocardial perfusion imaging (MPI) as fixed perfusion defects (FPD). The fate of such FPD is not well appraised. This study addressed this important issue in a large number of patients undergoing serial MPI in relation to type of intervening therapy.
Patients with prior MI or MPI-evidence of myocardial necrosis undergoing serial MPI without intervening acute coronary syndromes were included. The fate of necrosis by MPI on per-patient and per-region analysis was analyzed, factoring also the impact of intervening coronary revascularization (CR).
A total of 3691 patients with 25,837 regions were identified, including 1413 (38.3%) subjects with 3358 (13.0%) regions exhibiting necrosis. Serial MPI after 29±21 months confirmed the persistent presence of myocardial necrosis FPD in the vast majority of patients and regions (86%); the consistency was even higher in the presence of moderate or severe necrosis (99%). Neither type nor site of CR significantly impacted on the presence and extent of myocardial necrosis at multivariable analysis.
The finding of myocardial necrosis by MPI remains highly consistent over time, and is not significantly altered by CR.
KeywordsCoronary artery disease myocardial infarction myocardial necrosis myocardial perfusion imaging
Acute coronary syndromes
Coronary artery bypass grafting
Coronary artery disease
Left anterior descending
Left ventricular ejection fraction
Myocardial perfusion imaging
Percutaneous coronary intervention
This work was supported by Etisan, Rome, Italy.
- 5.Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, Drozdz J, Farsky PS, Feldman AM, Doenst T, Michler RE, Berman DS, Nicolau JC, Pellikka PA, Wrobel K, Alotti N, Asch FM, Favaloro LE, She L, Velazquez EJ, Jones RH. Panza JA; STICH Trial Investigators. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.CrossRefPubMedPubMedCentralGoogle Scholar
- 6.Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, Michler RE, Bonow RO, Doenst T, Petrie MC, Oh JK, She L, Moore VL, Desvigne-Nickens P, Sopko G. Rouleau JL; STICHES investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511–20.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Nudi F, Pinto A, Procaccini E, Neri G, Vetere M, Tomai F, Gaspardone A, Biondi-Zoccai G, Schillaci O. A novel clinically relevant segmentation method and corresponding maximal ischemia score to risk-stratify patients undergoing myocardial perfusion scintigraphy. J Nucl Cardiol. 2014;21:807–18.CrossRefPubMedGoogle Scholar
- 10.Nudi F, Schillaci O, Neri G, Pinto A, Procaccini E, Vetere M, Frati G, Tomai F, Biondi-Zoccai G. Prognostic impact of location and extent of vessel-related ischemia at myocardial perfusion scintigraphy in patients with or at risk for coronary artery disease. J Nucl Cardiol. 2016;23:274–84.CrossRefPubMedGoogle Scholar
- 11.Biondi-Zoccai G, Pinto AM, Versaci F, Procaccini E, Neri G, Sesti G, Uccioli L, Vetere M, Peruzzi M, Nudi F. Comparative impact of hypoglycemic agents on severity and extent of myocardial ischemia in patients with type 2 diabetes mellitus undergoing myocardial perfusion scintigraphy. J Cardiovasc Pharmacol. 2016;68:162–70.Google Scholar
- 12.Nudi F, Di Belardino N, Versaci F, Pinto A, Procaccini E, Neri G, Vetere M, Frati G, Peruzzi M, Schillaci O, Gaspardone A, Tomai F, Biondi-Zoccai G. Impact of coronary revascularization versus medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy. J Nucl Cardiol. 2016. doi: 10.1007/s12350-016-0504-5.
- 14.Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A. Iwanochko RM; PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: A randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.CrossRefPubMedGoogle Scholar
- 17.Ibrahim T, Bülow HP, Hackl T, Hörnke M, Nekolla SG, Breuer M, Schömig A, Schwaiger M. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol. 2007;49:208–16.CrossRefPubMedGoogle Scholar